0000-0002-0162-5294 About
Combined 19 years experience of teaching and research in various colleges and universities.
• Over 3 years of Industrial experience.
• Published 103 peer reviewed articles that including, 51 journal papers, 48 oral and poster presentation abstracts, 2 book chapters, 1 text book, and 1 US patent.
• Serve on the Editorial Boards/Panels of 37 different journals (in various capacities) and review manuscripts and books for 76 well known scientific publications (journals and books).
• Member of the United State Pharmacopeia (USP) Council of Experts (CoE), Povidones Panel.
• Member of the Royal Society of Chemistry (MRSC).
• Editor-in-Chief, Advances in Analytical Chemistry, and Medicinal and Aromatic Plant Research Journal.
• Executive Editor, Journal of Developing Drugs.
• Associate Editor, International Journal of Chemical Research.
• Section and Copy Editor, European Journal of Chemistry.
• Academic Editor, British Journal of Pharmaceutical Research.
• Editorial Board Member, Bulletin of Environmental Contamination and Toxicology.
• Pharmaceutical formulations (direct compressed tablets, topical and liquid).
• Ionic liquid formation and cocrystallization of the pharmaceutical compounds.
• Nano and micro-encapsulation of the drugs for targeting and controlled release.
• Multistep synthesis of small organic molecules.
• Pharmaceutical analysis (method development and forensic applications).
• Design and synthesis of novel monomeric and polymeric surfactants for separation of chiral and achiral compounds in micellar electrokinetic chromatography (MEKC).
• Expertise in method development and validation for separations of achiral and chiral compounds utilizing MEKC-UV/MS and HPLC-UV/MS.
• Biotransformation of pharmacologically active compounds using microbial whole cultures.
• Natural Product Isolation from fungal metabolites and medicinal plants and pharmacological evaluations.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.